GP130/STAT3 signalling in articular cartilage development and regeneration

GP130/STAT3信号在关节软骨发育和再生中的作用

基本信息

  • 批准号:
    10087887
  • 负责人:
  • 金额:
    $ 55.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-04-01 至 2023-01-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Articular cartilage is a highly specialized tissue that protects diarthrodial joints from forces associated with load bearing, and allows nearly frictionless motion between articular surfaces. Articular cartilage injury often leads to osteoarthritis (OA). OA currently affects more than 25 million people in the United States alone, making joint surface restoration a major priority in modern medicine. The regenerative capacity of adult articular cartilage has traditionally considered to be negligible, but several recent reports suggest that the regenerative potential of articular cartilage may be underestimated. Based on our preliminary data, we hypothesize that signaling through the Leukemia Inhibitory Factor Receptor-Glycoprotein 130/Janus Kinase/Signal Transducer and Activator of Transcription 3 (LIFR/gp130/JAK/STAT3) pathway is essential during devleopment, and can stimulate adult chondrocytes to assume a proliferative and migratory phenotype, similar to what occurs during fetal joint development, thereby promotimg the maintenance of articular cartilage. Moreover, we identified a novel small molecule termed Regulator of Cartilage Growth and Differentiation 423 (RCGD 423) that potently and selectively agonizes this pathway in a gp130-dependent manner. We therefore test whether manipulation of gp130-STAT3 signaling, both genetically or pharmacologically, can modulate the development and progression of OA. First, the role of LIFR and STAT3 signaling in establishment and maintenance of mouse cartilage during development will be defined. Next, we will test the consequences of gain and loss of STAT3 function in cartilage regeneration in a mouse injury model designed to mimic OA. The final set of experiments will evaluate the effects of RCGD 423 and test the hypothesis that this molecule acts by modulating gp130 signaling in mouse cartilage repair and degeneration. The experiments in this proposal are anticipated to define a novel function for LIFR-gp130/STAT3 signaling in cartilage establishment and repair, and to demonstrate that manipulation of this pathway can prevent degeneration in mouse models of osteoarthritis. If these experiments are successful, a critical new pathway regulating cartilage development, repair and degeneration will have been identified. In addition, a small molecule agonist of gp130 signaling that can slow the progression of articular cartilage degradation will be ready for pre-clinical testing and development.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DENIS EVSEENKO其他文献

DENIS EVSEENKO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DENIS EVSEENKO', 18)}}的其他基金

Preclinical assessment of a novel systemic drug candidate for osteoarthritic pain
治疗骨关节炎疼痛的新型全身候选药物的临床前评估
  • 批准号:
    10642544
  • 财政年份:
    2023
  • 资助金额:
    $ 55.3万
  • 项目类别:
Advancement of a lead small molecule gp130 modulator for improving outcomes in joint fibrosis
领先的小分子 gp130 调节剂的进展,用于改善关节纤维化的结果
  • 批准号:
    10482204
  • 财政年份:
    2022
  • 资助金额:
    $ 55.3万
  • 项目类别:
GP130/STAT3 signalling in articular cartilage development and regeneration
GP130/STAT3信号在关节软骨发育和再生中的作用
  • 批准号:
    10028195
  • 财政年份:
    2020
  • 资助金额:
    $ 55.3万
  • 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
  • 批准号:
    10541847
  • 财政年份:
    2019
  • 资助金额:
    $ 55.3万
  • 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
  • 批准号:
    10319573
  • 财政年份:
    2019
  • 资助金额:
    $ 55.3万
  • 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
  • 批准号:
    10062790
  • 财政年份:
    2019
  • 资助金额:
    $ 55.3万
  • 项目类别:
GP130/STAT3 signalling in articular cartilage development and regeneration
GP130/STAT3信号在关节软骨发育和再生中的作用
  • 批准号:
    10339375
  • 财政年份:
    2018
  • 资助金额:
    $ 55.3万
  • 项目类别:
GP130/STAT3 signalling in articular cartilage development and regeneration
GP130/STAT3信号在关节软骨发育和再生中的作用
  • 批准号:
    10562649
  • 财政年份:
    2018
  • 资助金额:
    $ 55.3万
  • 项目类别:
GP130/STAT3 signalling in articular cartilage development and regeneration
GP130/STAT3信号在关节软骨发育和再生中的作用
  • 批准号:
    10440806
  • 财政年份:
    2018
  • 资助金额:
    $ 55.3万
  • 项目类别:
Generation of human chondroprogenitor cells for cartilage restoration
用于软骨修复的人类软骨祖细胞的产生
  • 批准号:
    8304960
  • 财政年份:
    2011
  • 资助金额:
    $ 55.3万
  • 项目类别:

相似海外基金

Un/kindness, shame & resistance: the care of inpatients in NHS adult acute mental health units and how it might be improved
Un/善良,羞耻
  • 批准号:
    2885806
  • 财政年份:
    2023
  • 资助金额:
    $ 55.3万
  • 项目类别:
    Studentship
Post-Acute Care Transitions for Older Adult Medicare Beneficiaries with Serious Mental Illness
患有严重精神疾病的老年医疗保险受益人的急性后护理过渡
  • 批准号:
    10772386
  • 财政年份:
    2023
  • 资助金额:
    $ 55.3万
  • 项目类别:
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
  • 批准号:
    474619
  • 财政年份:
    2022
  • 资助金额:
    $ 55.3万
  • 项目类别:
    Operating Grants
Investigating the impact acute inhalation of cannabis with a high content of delta-9-tetrahydrocannabinol has on myelination and microglia in adult and aged mice
研究急性吸入高含量 delta-9-四氢大麻酚的大麻对成年和老年小鼠髓鞘形成和小胶质细胞的影响
  • 批准号:
    485965
  • 财政年份:
    2022
  • 资助金额:
    $ 55.3万
  • 项目类别:
    Studentship Programs
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
  • 批准号:
    466358
  • 财政年份:
    2022
  • 资助金额:
    $ 55.3万
  • 项目类别:
    Operating Grants
Metabolomics for prediction of cisplatin mediated acute kidney injury: a Canadian multi-centre adult and pediatric study
预测顺铂介导的急性肾损伤的代谢组学:加拿大多中心成人和儿童研究
  • 批准号:
    402040
  • 财政年份:
    2019
  • 资助金额:
    $ 55.3万
  • 项目类别:
    Operating Grants
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
  • 批准号:
    18K16103
  • 财政年份:
    2018
  • 资助金额:
    $ 55.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Causal effect of time-varying driving pressures on mortality in mechanically ventilated, adult patients with acute respiratory distress syndrome
时变驱动压力对机械通气成年急性呼吸窘迫综合征患者死亡率的因果影响
  • 批准号:
    377313
  • 财政年份:
    2017
  • 资助金额:
    $ 55.3万
  • 项目类别:
    Studentship Programs
Role of SETBP1 in adult Ph+ acute lymphoblastic leukemia
SETBP1 在成人 Ph 急性淋巴细胞白血病中的作用
  • 批准号:
    9315111
  • 财政年份:
    2016
  • 资助金额:
    $ 55.3万
  • 项目类别:
Acute Inhibition of Adult-born Granule Cells and its Effect on Antidepressant Act
成体颗粒细胞的急性抑制及其抗抑郁作用
  • 批准号:
    8734273
  • 财政年份:
    2013
  • 资助金额:
    $ 55.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了